儿童医院获得性静脉血栓栓塞风险评估模型的比较验证研究
该研究利用CHAT注册库(多中心儿童HA-VTE数据库)对3个儿童医院获得性静脉血栓栓塞风险评估模型进行外部验证,随机选取200例病例和200例对照。仅Arlikar等和Atchison等模型在非ICU和ICU亚组中分别显示良好校准。
要点
- 三个儿童HA-VTE风险评估模型区分度均优(AUROC≥0.85),但校准普遍不佳。
- 仅Arlikar模型在非ICU患者、Atchison模型在ICU患者中校准良好。
- 在临床应用或风险分层试验前,需进一步研究和优化儿童HA-VTE风险评估模型。
核心结论
- 所评估的儿童HA-VTE风险评估模型校准不足,临床应用前需进一步改进。
研究设计与样本
- 利用CHAT注册库(多中心儿童HA-VTE数据库)进行外部验证,随机选取200例病例和200例对照。
主要发现
- 三个模型AUROC均≥0.85,区分度优秀。
- Arlikar模型在非ICU患者、Atchison模型在ICU患者中区分度和校准均良好。
临床怎么用
- 当前儿童HA-VTE风险评估模型不宜直接用于临床或风险分层临床试验。
局限性
- 样本量有限(200例病例和200例对照),可能影响校准评估的稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk assessment models (RAMs) have been developed to identify children at high risk of hospital-acquired venous thromboembolism (HA-VTE). None have been externally validated nor compared. OBJECTIVES: The objective was to compare performance of these RAMs by externally validating them using the Children's Hospital-Acquired Thrombosis (CHAT) Registry, ie, a multicenter database of children with radiographic-confirmed HA-VTE and corresponding controls. PATIENTS/METHODS: Risk assessment models were included if the full logistic regression equation was available and all RAM variables were collected in the CHAT Registry. A random sample of 200 cases and 200 controls was selected. The performance of the RAMs was assessed for discrimination using area under the receiver operating characteristic curves (AUROC), and calibration using plots, slopes, and intercepts, and the Hosmer-Lemeshow test. RESULTS: Three RAMs were included. Each had excellent discrimination with AUROC ≥ 0.85. However, calibration was generally poor, with calibration slopes significantly different from 1 (0.71, P < .001; 1.44, P = .002; 0.68, P < .001), intercepts significantly different from 0 (-1.64, P < .001; -0.62, P < .001; 0.78, P < .001), and Hosmer-Lemeshow test P < .001 for each. Exceptions included the Arlikar et al and Atchison et al RAMs for pediatric HA-VTE in non-intensive care unit (ICU) patients and ICU patients, respectively, despite derivation from ICU and non-ICU patients, respectively. In these subpopulations, both showed excellent discrimination and good calibration. CONCLUSION: Given the lack of adequate calibration for evaluated RAMs, further investigation and refinement of RAMs for pediatric HA-VTE is needed prior to application of a RAM in a clinical setting or risk-stratified clinical trial of primary thromboprophylaxis against HA-VTE in children.
引用
- Mahajerin A, Jaffray J, Branchford B, et al. Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism. J Thromb Haemost. 2019. PMID: 31808292. doi:10.1111/jth.14697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。